Show simple item record

dc.contributor.authorHevia Urrutia, Francisco
dc.contributor.authorAlvarado Echeverría, Ileana
dc.contributor.authorSanabria Castro, Alfredo
dc.contributor.authorSánchez-Molina, Marta
dc.contributor.authorMeza Sierra, Luis
dc.contributor.authorParajeles Vindas, Alexander
dc.contributor.authorMéndez Blanca, Oscar
dc.contributor.authorSánchez Siles, Álvaro
dc.contributor.authorSaborío Rocafort, Manuel
dc.contributor.authorBarguil Gallardo, Marcela
dc.contributor.authorChavarría Quirós, Iliana
dc.contributor.authorMonge Bonilla, Cecilia
dc.date.accessioned2017-02-14T18:10:28Z
dc.date.available2017-02-14T18:10:28Z
dc.date.issued2017
dc.identifier.urihttp://hdl.handle.net/20.500.11764/635
dc.descriptionARTICULOes_ES
dc.description.abstractWilson’s disease is an inherited disorder in which defective biliary excretion of copper leads to its accumulation, particularly in the liver and brain. Mutations in the ATP7B gene on chromosome 13 cause Wilson’s disease. If left untreated it will cause liver failure, neurological damage, and will be life threatening. It is considered a rare disease afflicting approximately 1 in 30,000 persons worldwide, although this rate is similar in the different countries some places show higher incidence rates. Since Costa Rica reports the highest number of cases per population, essential public health initiatives that promote wellbeing, prevent disease complications, and prolong life among the affected population have been carried out during the last decades. The most recent lead in this matter is the conformation of the Costa Rica’s National Alliance for Wilson’s disease whose main objective is to provide practical, operational, timely and relevant guidance to patients, families, and healthcare professionals in the region for early diagnosis and treatment. The development and implementation of the National Alliance for Wilson’s disease activities is crucial because it will reaffirm that early intervention and appropriate treatment, will reduce if not eliminate the burden of Wilson’s disease.es_ES
dc.description.sponsorshipLos autoreses_ES
dc.language.isoenes_ES
dc.publisherBioMed Centrales_ES
dc.relation.ispartofseriesHepatology, Medicine and Policy;(2017) 2:5
dc.subjectDEGENERACION HEPATOLENTICULARes_ES
dc.subjectENFERMEDAD DE WILSONes_ES
dc.subjectPOLITICA DE SALUDes_ES
dc.subjectCOSTA RICAes_ES
dc.titleNational alliance for Wilson’s disease: health policy in Costa Ricaes_ES
dc.typeArticlees_ES


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record